Dual reporter MESP1mCherry/w-NKX2-5eGFP/w hESCs enable studying early human cardiac differentiation

Stem Cells

Volumn 33, Issue 1, 2015, Pages 56-67

  Den Hartogh, Sabine C ^a   Schreurs, Chantal ^a   Monshouwer Kloots, Jantine J ^a   Davis, Richard P ^a   Elliott, David A ^b   Mummery, Christine L ^a   Passier, Robert ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Cardiac differentiation; Cardiac progenitors; Embryonic stem cells; Mesoderm; MESP1; NKX2 5

Indexed keywords

CELL SURFACE MARKER; MICROSOMAL AMINOPEPTIDASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MESP1; TRANSCRIPTION FACTOR NKX2.5; TROPONIN T; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; GREEN FLUORESCENT PROTEIN; HOMEODOMAIN PROTEIN; HYBRID PROTEIN; MESP1 PROTEIN, HUMAN; NKX2-5 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC STEM CELL; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE ACTIVATED CELL SORTING; GENE TARGETING; GENOME ANALYSIS; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MESODERM; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TRANSIENT EXPRESSION; WNT SIGNALING PATHWAY; ANIMAL; CYTOLOGY; GENETICS; HEART MUSCLE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; HUMANS; MESODERM; MICE; MYOCARDIUM; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 84919430360     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1842     Document Type: Article

References (51)

1. Beqqali A, Kloots J, Ward-van Oostwaard D, et al. Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells 2006; 24: 1956-1967.
2. Keller G,. Embryonic stem cell differentiation: Emergence of a new era in biology and medicine. Genetics 2005; 19: 1129-1155.
3. Mummery CL, Zhang J, Ng ES, et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes a methods overview. Circ Res 2012; 111: 344-358.
4. Garry DJ, Olson EN,. A common progenitor at the heart of development. Cell 2006; 127: 1101-1104.
5. Kattman SJ, Huber TL, Keller GM,. Multipotent Flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006; 11: 723-732.
6. Moretti A, Caron L, Nakano A, et al. Multipotent Embryonic Isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006; 127: 1151-1165.
7. Abu-Issa R, Kirby ML,. Heart field: From mesoderm to heart tube. Annu Rev Cell Dev Biol 2007; 23: 45-68.
8. Saga Y, Miyagawa-Tomita S, Takagi A, et al. MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube. Development 1999; 126: 3437-3447.
9. Kitajima S, Takagi A, Inoue T, et al. MesP1 and MesP2 are essential for the development of cardiac mesoderm. Development 2000; 127: 3215-3226.
10. Kitajima S, Miyagawa-Tomita S, Inoue T, et al. Mesp1-nonexpressing cells contribute to the ventricular cardiac conduction system. Dev Dyn 2006; 235: 395-402.
11. Saga Y, Hata N, Kobayashi S, et al. MesP1: A novel basic helix-loop-helix protein expressed in the nascent mesodermal cells during mouse gastrulation. Development 1996; 122: 2769-2778.
12. Saga Y, Kitajima S, Miyagawa-Tomita S,. Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med 2000; 10: 345-352.
13. Lindsley RC, Gill JG, Murphy TL, et al. Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell 2008; 3: 55-68.
14. David R, Brenner C, Stieber J, et al. MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol 2008; 10: 338-345.
15. Bondue A, Lapouge G, Paulissen C, et al. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 2008; 3: 69-84.
16. Chan SS-K, Shi X, Toyama A, et al. Mesp1 patterns mesoderm into cardiac, hematopoietic, or skeletal myogenic progenitors in a context-dependent manner. Cell Stem Cell 2013; 12: 587-601.
17. Elliott DA, Braam SR, Koutsis K, et al. NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods 2011; 8: 1037-1040.
18. Ardehali R, Ali SR, Inlay MA, et al. Prospective isolation of human embryonic stem cell-derived cardiovascular progenitors that integrate into human fetal heart tissue. Proc Natl Acad Sci USA 2013; 110: 3405-3410.
19. Yang L, Soonpaa MH, Adler ED, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008; 453: 524-528.
20. Kattman SJ, Witty AD, Gagliardi M, et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011; 8: 228-240.
21. Costa M, Dottori M, Sourris K, et al. A method for genetic modification of human embryonic stem cells using electroporation. Nat Protoc 2007; 2: 792-796.
22. Davis RP, Costa M, Grandela C, et al. A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis. Nat Protoc 2008; 3: 1550-1558.
23. Costa M, Sourris K, Hatzistavrou T, et al. Expansion of human embryonic stem cells in vitro. Curr Protoc Stem Cell Biol 2008; 5: C:1C.1:1C.1.1-1C.1.7.
24. Ng ES, Davis R, Stanley EG, et al. A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat Protoc 2008; 3: 768-776.
25. Du P, Kibbe WA, Lin SM,. lumi: A pipeline for processing Illumina microarray. Bioinformatics 2008; 24: 1547-1548.
26. Smyth GK,. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article3.
27. Dubois NC, Craft AM, Sharma P, et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol 2011; 29: 1011-1018.
28. Skelton R, Costa M, Anderson DJ, et al. SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development. Stem Cell Res 2014; 13: 172-179.
29. Micallef SJ, Li X, Schiesser JV, et al. INS GFP/w human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells. Diabetologia 2011; 55: 694-706.
30. Davis RP, Ng ES, Costa M, et al. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 2008; 111: 1876-1884.
31. Wang P, Rodriguez RT, Wang J, et al. Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm. Cell Stem Cell 2011; 8: 335-346.
32. Cai Q, Bonfanti P, Sambathkumar R, et al. Prospectively isolated NGN3-expressing progenitors from human embryonic stem cells give rise to pancreatic endocrine cells. Stem Cells Transl Med 2014; 3: 489-499.
33. Bondue A, Tannler S, Chiapparo G, et al. Defining the earliest step of cardiovascular progenitor specification during embryonic stem cell differentiation. J Cell Biol 2011; 192: 751-765.
34. Paskaradevan S, Scott IC,. The Aplnr GPCR regulates myocardial progenitor development via a novel cell-non-autonomous, Gαi/o protein-independent pathway. Biol Open 2012; 1: 275-285.
35. Schenke-Layland K, Nsair A, Van Handel B, et al. Recapitulation of the embryonic cardiovascular progenitor cell niche. Biomaterials 2011; 32: 2748-2756.
36. Cheng P, Andersen P, Hassel D, et al. Fibronectin mediates mesendodermal cell fate decisions. Development 2013; 140: 2587-2596.
37. Hazeltine LB, Selekman JA, Palecek SP,. Engineering the human pluripotent stem cell microenvironment to direct cell fate. Biotechnol Adv 2013; 31: 1002-1019.
38. Yang JT, Rayburn H, Hynes RO,. Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 1993; 119: 1093-1105.
39. Mahlapuu M, Ormestad M, Enerback S, et al. The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm. Development 2001; 128: 155-166.
40. Lindsley RC, Gill JG, Kyba M, et al. Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm. Development 2006; 133: 3787-3796.
41. Noseda M, Peterkin T, Simoes FC, et al. Cardiopoietic factors: Extracellular signals for cardiac lineage commitment. Circ Res 2011; 108: 129-152.
42. Ueno S, Weidinger G, Osugi T, et al. Biphasic role for Wnt/β-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci USA 2007; 104: 9685-9690.
43. Lian X, hsiao C, Wilson G, et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling(2). Proc Natl Acad Sci USA 2012; 109: E1848-E1857.
44. Brade T, Manner J, Kuhl M,. The role of Wnt signalling in cardiac development and tissue remodelling in the mature heart. Cardiovasc Res 2006; 72: 198-209.
45. Mikels AJ, Nusse R,. Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context. PLoS Biol 2006; 4: e115.
46. Maye P,. Multiple mechanisms for Wnt11-mediated repression of the canonical Wnt signaling pathway. J Biol Chem 2004; 279: 24659-24665.
47. Povinelli BJ, Nemeth MJ,. Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor. Stem Cells 2014; 32: 105-115.
48. Tang C, Ardehali R, Rinkevich Y, et al. Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells. Nat Biotechnol 2012; 30: 531-542.
49. Passier R, Van Laake LW, Mummery CL,. Stem-cell-based therapy and lessons from the heart. Nature 2008; 453: 322-329.
50. Buikema JW, Meer P, Sluijter J, et al. Concise review: Engineering myocardial tissue: The convergence of stem cells biology and tissue engineering technology. Stem Cells 2013; 31: 2587-2598.
51. Hartogh den S, Sluijter J, Van Laake LW, et al. Cellular therapy for the infarcted myocardium. In: Translational Cardiology., Patterson, Cam, Willis, Monte, (Eds.), XVI, 544 p. Chapter 11. Springer, 2012.